title: A swine model of acute thrombocytopenia with prolonged bleeding time produced by busulfan.
abstract: Animal models of thrombocytopenia are indispensable for evaluating the in vivo efficacy of hemostatic agents, cryopreserved platelets, and artificial platelets, but no large animal models are available. In this study, we generated a swine model of acute thrombocytopenia with prolonged bleeding times by administering the chemotherapeutic drug busulfan. First, we tested multiple doses of busulfan (4, 6, and 8 mg/kg) in pigs, and found that 6 mg/kg of busulfan is an optimal dose for producing a safe and moderate thrombocytopenia, with a platelet count of less than 30,000/µl. The pigs administered 6 mg/kg of busulfan (n=8) reached half their initial counts at day 7, counts below 30,000/µl at day 12, and their nadirs at day 15 (on average). The minimal platelet count was 14,000/µl. With this dose of busulfan (6 mg/kg), bleeding times were significantly prolonged in addition to the decrease in platelet counts (r=-0.63, P<0.01), while there were no cases of apparent hemorrhage. White blood cell counts were maintained at over 5,000/µl, and there were no infections or other adverse events including anemia or appetite or body weight loss. All pigs were sacrificed on day 16, with subsequent examination showing a significant reduction in cellularity and colony-forming units in the bone marrow, indicating that thrombocytopenia was the result of myelosuppression. In summary, administration with 6 mg/kg of busulfan induces safe and moderate thrombocytopenia with a prolonged bleeding time in swine.
authors.affiliation: Division of Regenerative Medicine, Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi 329-0498, Japan.
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Abe
authors.forename: Shota
authors.initials: S
authors.lastname: Kono
authors.forename: Takahiro
authors.initials: T
authors.lastname: Ohnuki
authors.forename: Shuji
authors.initials: S
authors.lastname: Hishikawa
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kunita
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Hanazono
mesh_terms: D000208:Acute Disease; D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D001760:Bleeding Time; D002066:Busulfan / Q000009:adverse effects*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D005260:Female; D006403:Hematologic Tests; D006801:Humans; D008297:Male; D013552:Swine; D013556:Swine, Miniature; D013921:Thrombocytopenia / Q000209:etiology*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan